Monitoring and screening programs for patients with familial hypercholesterolemia
Familial hypercholesterolemia is the most common monogenic disease associated with the premature development of coronary heart disease. Awareness of the effectiveness, significance, and availability of screening programs aimed at identifying index patients and their relatives with familial hypercholesterolemia can lead to a significant decrease in the burden of cardiovascular disease. Early detection, initiation of adequate lipid-lowering therapy and monitoring of patients with familial hypercholesterolemia based on lipid centers will lead to decrease in mortality and disability from cardiovascular diseases.